Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Related to this story

Topics Medical, Public Policy, United States

WASHINGTON — The U.S. Food and Drug Administration is proposing an expedited approval for medical devices for devices aimed at the diagnosis or treatment of patients with serious conditions that would otherwise go untreated.

Introduced April 22, the “Expedited Access Premarket Approval Application for Unmet Medical Needs for Life Threatening or Irreversibly Debilitating Diseases or Conditions,” or “Expedited Access PMA” would include earlier and more engaged interaction with senior-level FDA staff which the agency believes will lead to faster patient access to safe medical devices. 

“We are excited to offer a proposed program for expedited access for certain high-risk medical devices,” said Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health. “The program allows manufacturers to engage early and often with the agency. We expect most devices that enter this program will be in the pre-clinical trial phase.” 

The program builds on the FDA’s experience with expedited review programs for pharmaceuticals and would be open to devices that are intended to treat or diagnose a life-threatening or irreversibly-debilitating disease or condition for which no approved alternative treatment or diagnostic equipment exists, or for a breakthrough technology that provides a clinical advantage over existing technology or approved alternatives. Participating device manufacturers must have an acceptable data development plan that has been approved by the FDA.

According to the agency, the Expedited Access PMA is not a new pathway to market, but a collaborative approach to facilitate product development under existing regulations. While other existing device programs have focused on reducing the time for pre-market review, the new approach, if adopted, would aim to also reduce the time associated with product development.

In a separate draft guidance, the also outlined the agency’s current policy on when data can be collected after product approval and what actions are available to the FDA if approval conditions, such as post-market data collection, are not met.

Included in the guidance is advice on the use of surrogate or independent markers to support approval, similar to the data points used for accelerated approval of prescription drugs.

Both proposals are open for public comment at www.fda.gov/medicaldevices


Comments

Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Post Your Comments


Back to story


More stories

Image

Report: Brands are falling short on packaging sustainability

January 29, 2015 5:19 pm ET

Packaging in general, and plastic packaging in particular, has a long way to go in terms of recycling, according to a pair of environmental groups.    More

Image

Lund adds to aftermarket auto products portfolio with buy of Bushwacker

January 29, 2015 2:49 pm ET

Lund International Inc. has expanded its portfolio of plastic aftermarket vehicle accessories by acquiring Bushwacker Inc.    More

Image

Chemtrusion, Mytex Indiana compounding plant set for expansion

January 29, 2015 1:35 pm ET

Japanese and American partners in a compounding plant in Indiana plan to expand the facility.    More

Image

Falcon Plastics expands in South Dakota

January 29, 2015 11:45 am ET

Falcon Plastics Inc. is putting the final touches on a 60,000 square foot addition that will nearly double the size of its Brookings, S.D.,...    More

Image

Plastics enter 2015 on a high note

January 29, 2015 10:10 am ET

Now that the preliminary round of December data is officially in the books, I can state unequivocally that 2014 was an outstanding year for the U.S. p...    More

Market Reports

Plastics in Automotive: Innovation & Emerging Trends

This special report newly released by PN and sponsored by The Conair Group examines current trends in the use of plastics in automotive, materials innovations and the changing landscape. It includes a review of legislative/regulatory activity impacting vehicle development and lightweighting, market opportunities & challenges for mold and toolmakers, innovative design strategies being implemented by major OEMs and suppliers, as well as a review of key indicators in Canada, Mexico, Brazil and China.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Injection Molding Market Analysis & Processor Rankings

Plastics News BUNDLED package contains our in-depth Market Analysis of the Injection Molding segment. You will gain keen insight on current trends and our economic outlook.

As a BONUS this includes PN's updated 2014 database of North American Injection Molders RANKED by sales volume. Sort, merge, mail & prospect by end market, materials processed, region, # of plants and more.

Learn more

Upcoming Plastics News Events

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

More Events